The aim of this study is to determine the degree of agreement in cytokines level measured through BAL and those measured through salivary glands excretion. and to compare the validity of cytokines in BAL versus salivary secretion in predicting the stage of ARDS and disease outcome in term of mortality, disease progression and length of stay.
• BAL will be performed by the attending pediatric intensivist in pediatric intensive care unit as part of standard care for ARDS management and Saliva samples will be collected non-invasively using sterile collection devices IL6 and TNF alfa will measured in both samples and compared to each other
Study Type
OBSERVATIONAL
Enrollment
37
Comparison between levels of inflammatory markers in both BAL \&salivary secretions
Ain shams university, Cairo
Cairo, Egypt
Agreement between BAL and salivary cytokine levels
Degree of agreement between cytokine concentrations measured in bronchoalveolar lavage (BAL) fluid and salivary gland secretions collected simultaneously, assessed using intraclass correlation coefficients and Bland-Altman analysis.
Time frame: Within 24 hours of ARDS diagnosis
Prediction of ARDS severity by cytokine levels
Ability of BAL and salivary cytokine levels to predict ARDS severity according to established criteria.
Time frame: First 48-72 hours
Association of cytokine levels with in-hospital mortality
Relationship between cytokine concentrations and all-cause in-hospital mortality.
Time frame: Through the study completion ( anaverage one year)
Association of cytokine levels with disease progression
Relationship between cytokine levels and worsening ARDS severity or escalation of respiratory support.
Time frame: Through the study completion of average one year
Association of cytokine levels with length of hospital stay
Relationship between cytokine concentrations and length of hospital stay.
Time frame: Through the study completion ( an average one year)
Comparative predictive performance of BAL versus salivary cytokines
Comparison of BAL and salivary cytokines in predicting ARDS severity, mortality, disease progression, and length of stay.
Time frame: Through a study completion of average one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.